IONIS PHARMACEUT reported $2.53B in Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Agios Pharmaceuticals AGIO:US USD 1.24B 58.4M
Alnylam Pharmaceuticals ALNY:US USD 3.55B 11.1M
Arrowhead Research ARWR:US USD 891.49M 199.55M
Astellas Pharma 4503:JP JPY 2.51T 69.71B
Biocryst Pharmaceuticals BCRX:US USD 550M 8.59M
Biomarin Pharmaceutical BMRN:US USD 6.38B 111.03M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Esperion Therapeutics ESPR:US USD 247.94M 64.89M
Exelixis EXEL:US USD 3.07B 110.12M
Halozyme Therapeutics HALO:US USD 1.84B 23.03M
Intercept Pharmaceuticals ICPT:US USD 553.71M 5.69M
Mirati Therapeutics MRTX:US USD 1.2B 100.44M
Moderna Inc MRNA:US USD 25.86B 198M
Nektar Therapeutics NKTR:US USD 710.6M 70.41M
Neurocrine Biosciences NBIX:US USD 2.37B 225.3M
Novartis NOVN:VX USD 117.45B 1.01B
Omeros OMER:US USD 590.97M 133.42M
Ptc Therapeutics PTCT:US USD 1.71B 129.22M
Regeneron Pharmaceuticals REGN:US USD 29.21B 1.54B
Roche Holding ROG:VX 88.15B 1.42B
Sarepta Therapeutics SRPT:US USD 3.13B 27.78M
Ultragenyx Pharmaceutical RARE:US USD 1.55B 73.03M
Vertex Pharmaceuticals VRTX:US USD 18.15B 1.44B